27299886|t|Low Soluble Syndecan-1 Precedes Preeclampsia
27299886|a|Syndecan-1 (Sdc1; CD138) is a major transmembrane heparan sulfate proteoglycan expressed on the extracellular, luminal surface of epithelial cells and syncytiotrophoblast, thus comprising a major component of the glycocalyx of these cells. The " soluble " (shed) form of Sdc1 has paracrine and autocrine functions and is normally produced in a regulated fashion. We compared plasma soluble Sdc1 concentrations, in relation to placental Sdc1 expression, in uncomplicated (control) and preeclamptic pregnancies. We evaluated soluble Sdc1 across uncomplicated pregnancy, and between preeclamptic, gestational hypertensive and control patients at mid-pregnancy (20 weeks) and 3rd trimester by ELISA. Placental expression level of Sdc1 was compared between groups in relation to pre-delivery plasma soluble Sdc1. Participants were recruited from Magee-Womens Hospital. In uncomplicated pregnancy, plasma soluble Sdc1 rose significantly in the 1st trimester, and reached an approximate 50-fold increase at term compared to post pregnancy levels. Soluble Sdc1 was lower at mid-pregnancy in women who later developed preeclampsia (P<0.05), but not gestational hypertension, compared to controls, and remained lower at late pregnancy in preeclampsia (P<0.01) compared to controls. Sdc1 was prominently expressed on syncytiotrophoblast of microvilli. Syncytiotrophoblast Sdc1 immunostaining intensities, and mRNA content in villous homogenates, were lower in preeclampsia vs. controls (P<0.05). Soluble Sdc1 and Sdc1 immunostaining scores were inversely associated with systolic blood pressures, and positively correlated with infant birth weight percentile. Soluble Sdc1 is significantly lower before the clinical onset of preeclampsia, with reduced expression of Sdc1 in the delivered placenta, suggesting a role for glycocalyx disturbance in preeclampsia pathophysiology.
27299886	12	22	Syndecan-1	T103	UMLS:C1609943
27299886	32	44	Preeclampsia	T038	UMLS:C0032914
27299886	45	55	Syndecan-1	T103	UMLS:C1609943
27299886	57	61	Sdc1	T103	UMLS:C1609943
27299886	63	68	CD138	T103	UMLS:C1609943
27299886	81	123	transmembrane heparan sulfate proteoglycan	T103	UMLS:C0062503
27299886	124	133	expressed	T038	UMLS:C1171362
27299886	141	154	extracellular	T017	UMLS:C0521119
27299886	156	171	luminal surface	T082	UMLS:C0205148
27299886	175	191	epithelial cells	T017	UMLS:C0014597
27299886	196	215	syncytiotrophoblast	T017	UMLS:C1515108
27299886	258	268	glycocalyx	T017	UMLS:C0061622
27299886	278	283	cells	T017	UMLS:C0007634
27299886	316	320	Sdc1	T103	UMLS:C1609943
27299886	325	334	paracrine	T038	UMLS:C2755743
27299886	339	358	autocrine functions	T038	UMLS:C2755742
27299886	420	426	plasma	T031	UMLS:C0032105
27299886	435	439	Sdc1	T103	UMLS:C1609943
27299886	471	480	placental	T017	UMLS:C0032043
27299886	481	485	Sdc1	T103	UMLS:C1609943
27299886	486	496	expression	T038	UMLS:C1171362
27299886	501	514	uncomplicated	T033	UMLS:C4314562
27299886	529	541	preeclamptic	T038	UMLS:C0032914
27299886	542	553	pregnancies	T038	UMLS:C0032961
27299886	576	580	Sdc1	T103	UMLS:C1609943
27299886	588	611	uncomplicated pregnancy	T033	UMLS:C4314562
27299886	625	637	preeclamptic	T038	UMLS:C0032914
27299886	639	663	gestational hypertensive	T038	UMLS:C0852036
27299886	734	739	ELISA	T058	UMLS:C0014441
27299886	741	750	Placental	T017	UMLS:C0032043
27299886	751	761	expression	T038	UMLS:C1171362
27299886	771	775	Sdc1	T103	UMLS:C1609943
27299886	797	803	groups	T098	UMLS:C1257890
27299886	832	838	plasma	T031	UMLS:C0032105
27299886	847	851	Sdc1	T103	UMLS:C1609943
27299886	853	865	Participants	T098	UMLS:C0679646
27299886	886	907	Magee-Womens Hospital	T092	UMLS:C0019994
27299886	912	935	uncomplicated pregnancy	T033	UMLS:C4314562
27299886	937	943	plasma	T031	UMLS:C0032105
27299886	952	956	Sdc1	T103	UMLS:C1609943
27299886	1093	1097	Sdc1	T103	UMLS:C1609943
27299886	1128	1133	women	T098	UMLS:C0043210
27299886	1154	1166	preeclampsia	T038	UMLS:C0032914
27299886	1185	1209	gestational hypertension	T038	UMLS:C0852036
27299886	1255	1269	late pregnancy	T038	UMLS:C0878751
27299886	1273	1285	preeclampsia	T038	UMLS:C0032914
27299886	1317	1321	Sdc1	T103	UMLS:C1609943
27299886	1338	1347	expressed	T038	UMLS:C1171362
27299886	1351	1370	syncytiotrophoblast	T017	UMLS:C1515108
27299886	1374	1384	microvilli	T017	UMLS:C0026049
27299886	1386	1405	Syncytiotrophoblast	T017	UMLS:C1515108
27299886	1406	1410	Sdc1	T103	UMLS:C1609943
27299886	1411	1437	immunostaining intensities	T058	UMLS:C4288189
27299886	1443	1447	mRNA	T103	UMLS:C0035696
27299886	1494	1506	preeclampsia	T038	UMLS:C0032914
27299886	1538	1542	Sdc1	T103	UMLS:C1609943
27299886	1547	1551	Sdc1	T103	UMLS:C1609943
27299886	1552	1566	immunostaining	T058	UMLS:C0487602
27299886	1605	1629	systolic blood pressures	T201	UMLS:C0871470
27299886	1702	1706	Sdc1	T103	UMLS:C1609943
27299886	1759	1771	preeclampsia	T038	UMLS:C0032914
27299886	1786	1796	expression	T038	UMLS:C1171362
27299886	1800	1804	Sdc1	T103	UMLS:C1609943
27299886	1812	1821	delivered	T033	UMLS:C0566687
27299886	1822	1830	placenta	T017	UMLS:C0032043
27299886	1854	1864	glycocalyx	T017	UMLS:C0061622
27299886	1880	1892	preeclampsia	T038	UMLS:C0032914
27299886	1893	1908	pathophysiology	T038	UMLS:C0277785